| Baseline (pre-intervention) | 12 months (post-intervention) | Within-group pre-post difference | |||||
---|---|---|---|---|---|---|---|---|
APHN | Control | p value | APHN | Control | p value | APHN (p value) | Control (p value) | |
PU risk assessment among candidates for extended care | 65% | 60% | 0.633 | 94% | 62% | <.001 | 29 pp. (0.000) | 1 pp. (0.878) |
PU risk reassessment | 12% | 13% | 0.816 | 83% | 16% | <.001 | 72 pp. (0.000) | 3 pp. (0.644) |
Daily assessment of skin condition | 7% | 2% | 0.322 | 69% | 22% | <.001 | 62 pp. (0.000) | 20 pp. (0.001) |
Barrier / moisturiser cream or oil | 72% | 70% | 0.807 | 89% | 47% | <.001 | 17 pp. (0.064) | −23 pp. (0.018) |
Daily record of skin condition | 0% | 43% | 0.000 | 97% | 36% | <.001 | 97 pp. (0.000) | −7 pp. (0.455) |
Postural changes scheduled | 67% | 55% | 0.205 | 92% | 67% | 0.007 | 24 pp. (0.009) | 13 pp. (0.181) |
Pressure modification/Pressure relief support (PMS/PRS) | 93% | 87% | 0.504 | 92% | 89% | 1.000 | −1 pp. (1.000) | 2 pp. (0.714) |
Nutritional assessment | 21% | 30% | 0.304 | 33% | 16% | 0.060 | 12 pp. (0.214) | −14 pp. (0.089) |
Full record of PU characteristics | 84% | 83% | 0.927 | 100% | 95% | 0.275 | 16 pp. (0.014) | 12 pp. (0.057) |
PU treatment schedule | 81% | 87% | 0.469 | 94% | 93% | 1.000 | 13 pp. (0.101) | 6 pp. (0.308) |
Patients’ and families’ understanding of condition | 58% | 60% | 0.824 | 86% | 78% | 0.343 | 28 pp. (0.006) | 18 pp. (0.045) |